Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy

Abstract Introduction A systematic literature review and network meta-analysis (NMA) were conducted to compare the short-term efficacy of lebrikizumab to other biologic and Janus kinase (JAK) inhibitor monotherapies approved for moderate-to-severe atopic dermatitis in adults and adolescents. Methods...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, Raj Chovatiya
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Adis, Springer Healthcare 2025-02-01
Colección:	Dermatology and Therapy
Materias:	Atopic dermatitis Eczema Area and Severity Index Investigator Global Assessment Lebrikizumab Network meta-analysis Pruritus/itch Numeric Rating Scale
Acceso en línea:	https://doi.org/10.1007/s13555-025-01357-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!